Phone:1-206-878-3900, Fax:1-888-878-1118 customerservice@keycompounding.com
Compounding Medications for  Men’s Health

Compounding Medications for Men’s Health

Special presentation by By Matthew Weisser, Pharm D Dr. Matt Weisser brings the most updated information about Men’s health issue. As a compounding pharmacist, he has accumulated an extensive knowledge to support Men”s health clinics nationwide over the years. He will cover how individually customized medicine for Men can improve your well beings. Men’s hormone therapy, ED, and anti-aging strategies for Men are some of topics. Please Join us.

Compounded treatments for erectile dysfunction: a common complication of diabetes

Compounded treatments for erectile dysfunction: a common complication of diabetes

Erectile dysfunction is a very common complication of diabetes; as many as 50% to 80% of men with diabetes experience some degree of erectile dysfunction. Erectile dysfunction in men with diabetes mellitus usually is a result of the vascular and autonomic dysfunctions that often accompany uncontrolled hyperglycemia. A number of treatment options can be offered to a patient experiencing this complication. Compounding allows for specialized dosage forms of medications; with the help of an attentive physician and a compounding pharmacist, successful treatment of erectile dysfunction can become a reality.

Color of wine matters

Color of wine matters

On the off-chance that you are a man who can not leave behind a glass of wine in supper, think about this. A glass of red wine a day brings down the risk of prostate cancer. To the contrary, white wine drinkers faced a slight uptick in prostate cancer risk according to a review published online April 17 in Clinical Epidemiology.

Your Access to Bioidentical Hormones Is Being Threatened

Your Access to Bioidentical Hormones Is Being Threatened

The FDA is proposing regulations that would allow massive drug companies to eliminate your access to compounded bioidentical hormones. YOUR ACTION IS NEEDED! Recently, the FDA released a list of nominations to its “Demonstrably Difficult to Compound” (DDC) list. This list derives from section 503A of the Food, Drug, and Cosmetic Act. It is supposed to identify drugs that cannot safely be compounded because of their complexity. The agency is threatening to take away the ability of compounding pharmacies to provide estriol, progesterone and testosterone to their patients, despite the fact that they have been safely providing these prescriptions for over 30 years.

^